Skip to content
Review

The Role of Preprocedural CT in Redo Transcatheter Aortic Valve Replacement: A Radiologist's Perspective.

Aug 2026 · Radiology: Cardiothoracic Imaging · Vol 8 4, pp. e250200 · 0 citations · 28 references
Medicine

TL;DR

Differences are primarily related to the need to evaluate the characteristics of the index THV and the degree of commissural and coronary alignment achieved during the index TAVR procedure, which affect the selection of the type and size of the new THV and determine the risks of coronary obstruction and impeded future coronary access, as well as the potential for leaflet modification.

Abstract

As transcatheter aortic valve replacement (TAVR) has become a viable option across all surgical risk levels, younger patients are anticipated to outlive the durability of their index transcatheter heart valve (THV). When a THV fails, cardiac CT is an important tool to assess the mechanism of THV failure and aids in the differentiation between structural and nonstructural THV dysfunction mechanisms. After the identification of the index THV dysfunction mechanism, CT guides the sizing and selection of the new THV type. While the principles of preprocedural redo TAVR (often called TAV-in-TAV) CT assessment overlap with those for patients undergoing TAVR of surgical bioprosthetic valves, the assessment is different in several ways. These differences are primarily related to the need to evaluate the characteristics of the index THV and the degree of commissural and coronary alignment achieved during the index TAVR procedure, which affect the selection of the type and size of the new THV and determine the risks of coronary obstruction and impeded future coronary access, as well as the potential for leaflet modification. Keywords: Applications-CT, CT Angiography, Transcatheter Aortic Valve Implantation/Replacement, TAVI/TAVR Supplemental material is available for this article. ©RSNA, 2026.

View source

Similar papers

Open access Sep 2026

Transcatheter tricuspid valve replacement—a comparison of clinical and procedural outcomes of two different prostheses

Background Transcatheter Tricuspid Valve Replacement (TTVR) has emerged as a treatment option for patients with severe tricuspid regurgitation (TR) who are at high surgical risk and unsuitable for tricuspid transcatheter edge-to-edge repair (T-TEER). Objectives This study aims to compare procedural, clinical and echoca...

Florian Genske, Judith Heine, C. Marquetand et al. · 0 citations
Open access Aug 2026

Redo-Transcatheter Aortic Valve Replacement With Self-Expanding Valves: A U.S. Registry Analysis.

BACKGROUND Redo-transcatheter aortic valve replacement (TAVR) for failed transcatheter heart valves is expected to increase, but data on outcomes with self-expanding valves remain limited. OBJECTIVES The aims of this study were to evaluate procedural, clinical, and quality-of-life outcomes following redo-TAVR using s...

Toby Rogers, V. Bapat, S. Chetcuti et al. · 1 citation
Review Open access Aug 2026

Transcatheter atrioventricular valve-in-valve re-replacement with balloon-expandable prostheses: contemporary clinical relevance and place among redo valve interventions

Introduction: The steadily increasing number of patients with structural degeneration of bioprosthetic heart valves necessitates the search for alternatives to redo open surgery, which is associated with high operative risk due to resternotomy, adhesions, repeat cardiopulmonary bypass, and an unfavorable comorbidity pr...

A. Gorbatykh · 0 citations
Review Open access Aug 2026

Advanced 3D echocardiographic assessment of the aortic valve and aortic root complex: a repair-oriented perspective

Three-dimensional echocardiography, particularly transoesophageal 3DE, has become an essential imaging modality for integrating anatomical and functional information and plays a pivotal role in promoting a repair-oriented approach to the management of aortic valve disease.

T. Viva, C. Fiore, R. Dulgheru et al. · 0 citations
Editorial Open access Aug 2026

When redo-transcatheter aortic valve replacement (TAVR) is not enough: self-expanding TAVR explant and the next frontier of lifetime valve management

a practical, rather than theoretical, issue (3). Reintervention after TAVR remains uncommon on a per-patient basis, yet the absolute number is rising: in the FRANCE 2 and FRANCE TAVI registries, cumulative reintervention reached 1.7% at 8 years, and in a recent Centers for Medicare & Medicaid Services (CMS) analysis of...

Ahmad Shrouf, Ahmad Jabri, M. Abdalaziz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.